PRPH 2.45 (-6.84%)
US74345W1080Drug ManufacturersDrug Manufacturers - Specialty & Generic

ProPhase Labs (PRPH) Competitor Comparison

We are evaluating the key criteria listed to compare ProPhase Labs (PRPH) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 5 years - PRPH ranking 7 / 54

These are the competitors of ProPhase Labs in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 5 years
1. Phibro Animal Health PAHC
66.63
2. Alvotech ALVO
55.2
3. Kamada KMDA
39.33
4. Supernus Pharmaceuticals SUPN
28.98
5. Evolus EOLS
17.74
6. Catalent CTLT
16.19
7. ProPhase Labs PRPH
14.02
8. Regencell Bioscience Holdings RGC
13
9. PetIQ PETQ
8.66
10. Neoleukin Therapeutics NLTX
8.58
11. Green Thumb Industries R9U2.F
7.38
12. Vifor Pharma G2AB.F
7.23
13. ANI Pharmaceuticals ANIP
6.32
14. Alimera Sciences ALIM
6.21
15. Relmada Therapeutics RLMD
6.01
16. Ironwood Pharmaceuticals IRWD
5.24
17. Pacira BioSciences PCRX
4.93
18. Kolinpharma KIP.MI
4.88
19. Organogenesis Holdings ORGO
4.82
20. Elanco Animal Health ELAN
4.41
21. Ayr Wellness 3KJB.F
4.19
22. Zoetis ZTS
4.09
23. Perrigo PRGO
3.99
24. Linc LNC
3.81
25. Curaleaf Holdings CURLF
3.73
26. Taro Pharmaceutical Industries TARO
3.55
27. Bausch Health Companies BHC
2.95
28. Emergent BioSolutions EBS
2.88
29. Procaps Group PROC
2.81
30. Journey Medical DERM
2.76
31. Embecta EMBC
2.58
32. Zynerba Pharmaceuticals ZYNE
2.47
33. Cumberland Pharmaceuticals CPIX
2.4
34. Jupiter Wellness JUPW
2.39
35. Eagle Pharmaceuticals EGRX
2.29
36. Societal CDMO SCTL
2.21
37. Cronos Group CRON
2.15
38. Theratechnologies THTX
1.97
39. SCYNEXIS SCYX
1.95
40. Clever Leaves Holdings CLVR
1.87
41. OptiNose OPTN
1.83
42. Alpha Teknova TKNO
1.79
43. Ascend Wellness Holdings AAWH
1.77
44. Biofrontera BFRI
1.74
45. Flora Growth FLGC
1.63
46. Universe Pharmaceuticals UPC
1.61
47. Tilray Brands TLRY
1.56
48. Solid Biosciences SLDB
1.45
49. Amphastar Pharmaceuticals AMPH
1.41
50. Teva Pharmaceutical Industries TEVA
0.98
51. Amneal Pharmaceuticals AMRX
0.84
52. Collegium Pharmaceutical COLL
0.83
53. Avadel Pharmaceuticals AVDL
0.78
54. Harrow Health HROW
0.45

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.